Recombinant Coagulation Factors Market Report

Global and Region Recombinant Coagulation Factors Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：219
  • REPORT CODE：GMM914732
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Recombinant Coagulation Factors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Coagulation Factorsmarket, defines the market attractiveness level of Recombinant Coagulation Factors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Recombinant Coagulation Factors industry, describes the types of Recombinant Coagulation Factors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Coagulation Factors market and the development prospects and opportunities of Recombinant Coagulation Factors industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Coagulation Factors market in Chapter 13.

    By Player:

    • Biogen Idec

    • Wyeth

    • CSL Ltd

    • Grifols International

    • Novo Nordisk

    • Kedrion

    • Bayer

    • Baxter International

    • Emergent BioSolutions

    • Octapharma AG

    • Pfizer

    By Type:

    • Recombinant Factor VIII

    • Recombinant Factor IX

    • Von Willebrand Factor

    • Other

    By End-User:

    • Hospitals

    • Clinics

    • Research Organizations

    • Academic Institutes

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Recombinant Coagulation Factors Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Recombinant Coagulation Factors Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Recombinant Coagulation Factors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Recombinant Coagulation Factors Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Recombinant Coagulation Factors Market Analysis and Outlook to 2022

    • 7.1 Global Recombinant Coagulation Factors Consumption (2017-2022)

    • 7.2 United States Recombinant Coagulation Factors Consumption (2017-2022)

    • 7.3 Europe Recombinant Coagulation Factors Consumption (2017-2022)

    • 7.4 China Recombinant Coagulation Factors Consumption (2017-2022)

    • 7.5 Japan Recombinant Coagulation Factors Consumption (2017-2022)

    • 7.6 India Recombinant Coagulation Factors Consumption (2017-2022)

    • 7.7 South Korea Recombinant Coagulation Factors Consumption (2017-2022)

    8 Region and Country-wise Recombinant Coagulation Factors Market Analysis and Outlook to 2028

    • 8.1 Global Recombinant Coagulation Factors Consumption Forecast (2022-2028)

    • 8.2 United States Recombinant Coagulation Factors Consumption Forecast (2022-2028)

    • 8.3 Europe Recombinant Coagulation Factors Consumption Forecast (2022-2028)

    • 8.4 China Recombinant Coagulation Factors Consumption Forecast (2022-2028)

    • 8.5 Japan Recombinant Coagulation Factors Consumption Forecast (2022-2028)

    • 8.6 India Recombinant Coagulation Factors Consumption Forecast (2022-2028)

    • 8.7 South Korea Recombinant Coagulation Factors Consumption Forecast (2022-2028)

    9 Global Recombinant Coagulation Factors Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Coagulation Factors Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Recombinant Factor IX Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Von Willebrand Factor Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Coagulation Factors Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Organizations Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Academic Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Recombinant Coagulation Factors Market Outlook by Types and Applications to 2028

    • 10.1 Global Recombinant Coagulation Factors Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Recombinant Factor IX Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Von Willebrand Factor Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Recombinant Coagulation Factors Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Academic Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Recombinant Coagulation Factors Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Recombinant Coagulation Factors Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Recombinant Coagulation Factors Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Recombinant Coagulation Factors Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Recombinant Coagulation Factors Market Competitive Analysis

    • 14.1 Biogen Idec

      • 14.1.1 Biogen Idec Company Details

      • 14.1.2 Biogen Idec Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Biogen Idec Recombinant Coagulation Factors Product and Service

    • 14.2 Wyeth

      • 14.2.1 Wyeth Company Details

      • 14.2.2 Wyeth Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Wyeth Recombinant Coagulation Factors Product and Service

    • 14.3 CSL Ltd

      • 14.3.1 CSL Ltd Company Details

      • 14.3.2 CSL Ltd Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 CSL Ltd Recombinant Coagulation Factors Product and Service

    • 14.4 Grifols International

      • 14.4.1 Grifols International Company Details

      • 14.4.2 Grifols International Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Grifols International Recombinant Coagulation Factors Product and Service

    • 14.5 Novo Nordisk

      • 14.5.1 Novo Nordisk Company Details

      • 14.5.2 Novo Nordisk Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novo Nordisk Recombinant Coagulation Factors Product and Service

    • 14.6 Kedrion

      • 14.6.1 Kedrion Company Details

      • 14.6.2 Kedrion Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Kedrion Recombinant Coagulation Factors Product and Service

    • 14.7 Bayer

      • 14.7.1 Bayer Company Details

      • 14.7.2 Bayer Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bayer Recombinant Coagulation Factors Product and Service

    • 14.8 Baxter International

      • 14.8.1 Baxter International Company Details

      • 14.8.2 Baxter International Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Baxter International Recombinant Coagulation Factors Product and Service

    • 14.9 Emergent BioSolutions

      • 14.9.1 Emergent BioSolutions Company Details

      • 14.9.2 Emergent BioSolutions Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Emergent BioSolutions Recombinant Coagulation Factors Product and Service

    • 14.10 Octapharma AG

      • 14.10.1 Octapharma AG Company Details

      • 14.10.2 Octapharma AG Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Octapharma AG Recombinant Coagulation Factors Product and Service

    • 14.11 Pfizer

      • 14.11.1 Pfizer Company Details

      • 14.11.2 Pfizer Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Pfizer Recombinant Coagulation Factors Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Recombinant Coagulation Factors

    • Figure Recombinant Coagulation Factors Picture

    • Table Global Recombinant Coagulation Factors Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Coagulation Factors Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Coagulation Factors Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Recombinant Coagulation Factors Consumption by Country (2017-2022)

    • Figure United States Recombinant Coagulation Factors Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Coagulation Factors Consumption and Growth Rate (2017-2022)

    • Figure China Recombinant Coagulation Factors Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Coagulation Factors Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Coagulation Factors Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Coagulation Factors Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Coagulation Factors Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Coagulation Factors Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Coagulation Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Recombinant Coagulation Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Coagulation Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Coagulation Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Coagulation Factors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Factor VIII Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Factor IX Consumption and Growth Rate (2017-2022)

    • Figure Global Von Willebrand Factor Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Research Organizations Consumption and Growth Rate (2017-2022)

    • Figure Global Academic Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Factor VIII Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Factor IX Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Von Willebrand Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Recombinant Coagulation Factors Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Recombinant Coagulation Factors Export by Region (Top 5 Countries) (2017-2028)

    • Table Biogen Idec (Foundation Year, Company Profile and etc.)

    • Table Biogen Idec Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Idec Recombinant Coagulation Factors Product and Service

    • Table Wyeth (Foundation Year, Company Profile and etc.)

    • Table Wyeth Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wyeth Recombinant Coagulation Factors Product and Service

    • Table CSL Ltd (Foundation Year, Company Profile and etc.)

    • Table CSL Ltd Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Ltd Recombinant Coagulation Factors Product and Service

    • Table Grifols International (Foundation Year, Company Profile and etc.)

    • Table Grifols International Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grifols International Recombinant Coagulation Factors Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Recombinant Coagulation Factors Product and Service

    • Table Kedrion (Foundation Year, Company Profile and etc.)

    • Table Kedrion Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kedrion Recombinant Coagulation Factors Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Recombinant Coagulation Factors Product and Service

    • Table Baxter International (Foundation Year, Company Profile and etc.)

    • Table Baxter International Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter International Recombinant Coagulation Factors Product and Service

    • Table Emergent BioSolutions (Foundation Year, Company Profile and etc.)

    • Table Emergent BioSolutions Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent BioSolutions Recombinant Coagulation Factors Product and Service

    • Table Octapharma AG (Foundation Year, Company Profile and etc.)

    • Table Octapharma AG Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Octapharma AG Recombinant Coagulation Factors Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Recombinant Coagulation Factors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Recombinant Coagulation Factors Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US